- Advertisement -
This high-risk moment is the culmination of a case that began, in essence, six years ago when The Wall Street Journal uncovered that Theranos had misrepresented the abilities of its blood testing machines. Regulators cracked down on the company, which led to its unravelling. In 2018, Theranos…

